Enosi Life Sciences Appoints Biotech, Pharma and Venture Capital Veteran Dr. James N. Woody as Executive Chairman

NASDAQ Market News

NEXT STORY
Novan Provides Pipeline and Priority Development Programs Update
PREV STORY
Myovant Sciences Presents Additional Data on Bone Mineral Density in Women with Uterine Fibroids from Phase 3 LIBERTY Program and from Prospective Observational Study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals to Present at the 2019 H.C Wainwright Global Life Sciences Conference

author_avatar
NASDAQ Market News

Apellis and Sobi: The New England Journal of Medicine Publishes Phase 3 PEGASUS Study Results Comparing Pegcetacoplan to Eculizumab for PNH

author_avatar
NASDAQ Market News